{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:14:37Z","timestamp":1786994077149,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012513","name":"Biomedical Research Network Centre in Cardiovascular Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.medcli.2025.107242","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:16:52Z","timestamp":1767781012000},"page":"107242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Presentaci\u00f3n cl\u00ednica y pron\u00f3stico de la amiloidosis cardiaca por transtirretina en funci\u00f3n del g\u00e9nero. An\u00e1lisis del registro de amiloidosis cardiaca de Galicia (AMIGAL)"],"prefix":"10.1016","volume":"166","author":[{"given":"Daniel","family":"Enr\u00edquez-V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Barge-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Porto-Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"L\u00f3pez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonz\u00e1lez-Babarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Guti\u00e9rrez-Feijoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Bilbao-Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"G\u00f3mez-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Varela-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda G.","family":"Crespo-Leiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Barge-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2025.107242_bib0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","article-title":"Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"31","author":"Buxbaum","year":"2024","journal-title":"Amyloid."},{"key":"10.1016\/j.medcli.2025.107242_bib0170","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2025.107242_bib0175","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2022.01.036","article-title":"Critical comparison of documents from scientific societies on cardiac amyloidosis: JACC state-of-the-art review","volume":"79","author":"Rapezzi","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.medcli.2025.107242_bib0180","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2025.107242_bib0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.amjcard.2021.02.035","article-title":"Causes of cardiovascular hospitalization and death in patients with transthyretin amyloid cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])","volume":"148","author":"Miller","year":"2021","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.medcli.2025.107242_bib0190","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.medcli.2024.01.005","article-title":"Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis","volume":"162","author":"Enr\u00edquez-V\u00e1zquez","year":"2024","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.medcli.2025.107242_bib0195","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.recesp.2021.07.007","article-title":"Characterization of hereditary transthyretin cardiac amyloidosis in Spain","volume":"75","author":"\u00c1lvarez-Rubio","year":"2022","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.medcli.2025.107242_bib0200","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jchf.2021.05.005","article-title":"Sex-related risk of cardiac involvement in hereditary transthyretin amyloidosis: insights from THAOS","volume":"9","author":"Caponetti","year":"2021","journal-title":"JACC Heart failure."},{"key":"10.1016\/j.medcli.2025.107242_bib0205","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.medcli.2025.107242_bib0210","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2025.107242_bib0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.recesp.2019.12.017","article-title":"Clinical profile and outcome of cardiac amyloidois in a Spanish referral center","volume":"74","author":"L\u00f3pez-Sainz","year":"2021","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.medcli.2025.107242_bib0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.medcli.2021.10.018","article-title":"Cardiac amyloidosis: description of a series of 143 cases","volume":"159","author":"Barge-Caballero","year":"2022","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.medcli.2025.107242_bib0225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10741-023-10339-w","article-title":"Sex differences in transthyretin cardiac amyloidosis","volume":"29","author":"Aimo","year":"2024","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.medcli.2025.107242_bib0230","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000098","article-title":"Senile systemic amyloidosis: clinical features at presentation and outcome","volume":"2","author":"Pinney","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.medcli.2025.107242_bib0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol Sex Differ."},{"key":"10.1016\/j.medcli.2025.107242_bib0240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40119-022-00265-7","article-title":"Sex differences in wild-type transthyretin amyloidosis: an analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"11","author":"Campbell","year":"2022","journal-title":"Cardiol Ther."},{"key":"10.1016\/j.medcli.2025.107242_bib0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10741-020-10010-8","article-title":"Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges","volume":"26","author":"Bruno","year":"2021","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.medcli.2025.107242_bib0250","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure","volume":"40","author":"Lam","year":"2019","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2025.107242_bib0255","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","article-title":"Sex\/gender differences in cardiovascular disease prevention: what a difference a decade makes","volume":"124","author":"Mosca","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.medcli.2025.107242_bib0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2021.10.007","article-title":"Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy","volume":"79","author":"Takashio","year":"2022","journal-title":"J Cardiol."},{"key":"10.1016\/j.medcli.2025.107242_bib0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2021.12.048","article-title":"Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis","volume":"351","author":"Zampieri","year":"2022","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.medcli.2025.107242_bib0270","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/ejhf.2646","article-title":"Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosis","volume":"24","author":"Patel","year":"2022","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.medcli.2025.107242_bib0275","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1253\/circrep.CR-21-0067","article-title":"Wild-type transthyretin amyloidosis in female patients-consideration of sex differences","volume":"3","author":"Ochi","year":"2021","journal-title":"Circ Rep."},{"key":"10.1016\/j.medcli.2025.107242_bib0280","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cardfail.2021.10.006","article-title":"Sex differences in heart failure","volume":"28","author":"Lala","year":"2022","journal-title":"J Card Fail."},{"key":"10.1016\/j.medcli.2025.107242_bib0285","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2025.107242_bib0290","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2025.107242_bib0295","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009637","article-title":"Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy","volume":"15","author":"Elliott","year":"2022","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.medcli.2025.107242_bib0300","article-title":"Representation of women in heart failure clinical trials: barriers to enrollment and strategies to close the gap","volume":"13","author":"Reza","year":"2022","journal-title":"Am Heart J Plus."},{"key":"10.1016\/j.medcli.2025.107242_bib0305","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1186\/s13063-022-07004-2","article-title":"Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis","volume":"23","author":"Daitch","year":"2022","journal-title":"Trials."},{"key":"10.1016\/j.medcli.2025.107242_bib0310","first-page":"253","article-title":"Differential aspects in heart failure in women","volume":"54","author":"Alonso","year":"2019","journal-title":"REC: CardioClinics."},{"key":"10.1016\/j.medcli.2025.107242_bib0315","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014742","article-title":"Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis","volume":"9","author":"Zhao","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.medcli.2025.107242_bib0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2018.09.081","article-title":"Differential impact of heart failure with reduced ejection fraction on men and women","volume":"73","author":"Dewan","year":"2019","journal-title":"J Am Coll Cardiol."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325004701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325004701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:10:58Z","timestamp":1771942258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775325004701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0025775325004701"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107242","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presentaci\u00f3n cl\u00ednica y pron\u00f3stico de la amiloidosis cardiaca por transtirretina en funci\u00f3n del g\u00e9nero. An\u00e1lisis del registro de amiloidosis cardiaca de Galicia (AMIGAL)","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107242"}}